Who has invested in Etiome?

Flagship Pioneering are named among the investors backing Etiome.

Etiome Funding: $50M Raised, Series A (2025)

Etiome funding overview

Etiome is a Biotech company based in Boston, Massachusetts. Etiome has raised $50M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in April 2025. The round record for Etiome runs through 2025; nothing later has been disclosed. Investors on record include Flagship Pioneering.

Etiome at a glance

Total raised: $50M
Latest round: Series A
Latest round date: April 2025
Industry: Biotech
Headquarters: Boston, Massachusetts
Notable investors: Flagship Pioneering

Frequently asked about Etiome funding

How much has Etiome raised?: Etiome has raised $50M in total disclosed funding across the rounds on record.
Who has invested in Etiome?: Flagship Pioneering are named among the investors backing Etiome.
What was the latest Etiome funding round?: The most recent disclosed round is a Series A, announced in April 2025.
Where is Etiome based?: Etiome is based in Boston, Massachusetts.
What sector does Etiome operate in?: Etiome is tracked under Biotech from Boston, Massachusetts, with $50M in disclosed funding.
When did Etiome last raise?: The last disclosed Etiome round closed in April 2025 at Series A.

Every Etiome figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare Biotech companies in Boston at a similar stage.

Etiome Funding: $50M Raised, Series A (2025)

Etiome funding overview

Etiome at a glance

Frequently asked about Etiome funding

Companies related to Etiome (40)

Browse related funding lists (6)